Home › German drug maker Bayer sees stronger profits from new blood thinner, eye drug
 

Keywords :   


German drug maker Bayer sees stronger profits from new blood thinner, eye drug

2013-10-31 13:39:31| Chemicals - Topix.net

Drug and materials company Bayer AG says net profit rose 42 per cent as sales increased for its new drugs aimed at preventing blood clots and treating the eye disease macular degeneration, while one-time expenses dropped.

Tags: german blood eye drug

Category:Chemicals

Latest from this category

All news
28.09Weekly Recap: AkzoNobel, BASF, Axalta, PPG Top This Weeks Stories
27.09Positive Development for Jotun After First Eight Months of 2028
27.09Graco Signs Definitive Agreement to Acquire Corob
27.09BASF Presents New Corporate Strategy
26.09Advanced Polymer Coatings Signs Deal to Coat for New Build Tankers Union Maritime
26.09Jeff McManus Appointed Senior VP of Americas at allnex
26.09AkzoNobel Develops Particle Technology for Metal Effect Powder Coatings
26.09Behr Paint Company Introduces Women in Paint in Canada
Chemicals »
29.09Eastern North Pacific Tropical Weather Outlook
29.09Atlantic Tropical Weather Outlook
29.09Hurricane Isaac Graphics
29.09Hurricane Isaac Forecast Discussion Number 13
29.09Tropical Storm Joyce Graphics
29.09Hurricane Isaac Wind Speed Probabilities Number 13
29.09Hurricane Isaac Public Advisory Number 13
29.09Summary for Hurricane Isaac (AT5/AL102024)
More »